Maternal and fetal inherited thrombophilias are not related to the development of severe preeclampsia

American Journal of Obstetrics and Gynecology

Volumn 185, Issue 1, 2001, Pages 153-157

  Livingston, Jeffrey C ^a,b   Barton, John R ^a,b   Park, Vicki ^a,b   Haddad, Bassam ^a,b   Phillips, Owen ^a,b   Sibai, Baha M ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b NONE   (United States)

Author keywords

Preeclampsia; Pregnancy; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; METHYLENETETRAHYDROFOLIC ACID; PROTHROMBIN;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; FETUS; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HEMOLYSIS; HUMAN; HUMAN CELL; INHERITANCE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MUTATION RATE; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOPHILIA;

EID: 0034924655     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2001.114691     Document Type: Article

References (25)

1. Increased frequency of genetic thrombophilia in women with complications of pregnancy
2. Activated protein C resistance and adverse pregnancy outcome
3. Inherited thrombophilia and pregnancy
4. Methylenetetrahydrofolate reductase polymorphism and preeclampsia
5. Severe preeclampsia associated with coinheritance of factor V Leiden mutation and protein S deficiency
6. The factor V Leiden mutation may predispose women to severe preeclampsia
7. Fetal carriers of the factor V Leiden mutation are prone to miscarriage and placental infarction
8. Thrombophilia: A mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta
9. Factor V Leiden is associated with repeated and recurrent unexplained fetal losses
10. Ethnic distribution of factor V Leiden in 4047 men and women: Implications for venous thromboembolism screening
11. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk for venous thrombosis
12. Increased risk for venous thrombosis in carriers of prothrombin G (A20210 variant)
13. Population study of the G1691A mutation (R506Q. FV Leiden) in the human factor V gene that is associated with resistance to activated protein C
14. Reliable genotyping of the G-20210-A mutation of coagulation factor II (prothrombin)
15. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
16. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia
17. Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies
18. Elevated homocyst(e)ine levels with preeclampsia
19. Factor V Leiden, C > T MTHFR polymorphism and genetic susceptibility to preeclampsia
20. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort
21. Prospective evaluation of the risk conferred by factor V Leiden and thermolabile methylenetetrahydrofolate reductase polymorphisms in pregnancy
22. Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia
23. Preeclampsia and genetic risk factors for thrombosis: A case-control study
24. A fetal fatty acid oxidation disorder as a cause of liver disease in pregnant women
25. Chronic reduction in fetal blood flow is associated with placental infarction